Press Releases

HELSINKI, Finland, Nov. 18, 2019 /PRNewswire/ -- Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.1 million in funding from the EU's Horizon 2020 program. The EU grant was awarded to support Aiforia's ongoing development work of its artificial intelligence (AI) solutions for digital path

WEBSTER, Texas, Nov. 18, 2019 /PRNewswire/ -- Jonas Fitness, the industry leader in Club Management Software, was announced last week as the 2019 Medical Fitness Association's Industry Partner

SANTA CLARA, Calif., Nov. 18, 2019 /PRNewswire/ -- Today eHealth, Inc. (NASDAQ: EHTH) (eHealth.com) released a

CHICAGO, Nov. 18, 2019 /PRNewswire/ -- HealthScape Advisors, a Convey Health Solutions company advising clients in the healthcare industry, has been recognized as a Top 10 Supplier in Modern Healthcare's 2019 Best Places to Work in Healthcare. This award identifies and recognizes outstanding employers in the healthcare industry nationwide.

NEW YORK, Nov. 18, 2019 /PRNewswire/ -- The largest private funder of suicide prevention research, the American Foundation for Suicide Prevention (AFSP), along with the Internat

MAPLE GROVE, Minn., Nov. 18, 2019 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added Zembrace® SymTouch&r

CAMBRIDGE, Mass., Nov. 18, 2019 /PRNewswire/ -- Nexcelom Biosciences announced the donation of five Cellometer Auto 2000 Automated Cell Viability Counters to LabCentral. This will support advances in cell-based assays and cellular analysis. Nexcelom has built a solid reputation for helping the scientific community understand the value of using fluorescent dye-based

TORONTO, Nov. 18, 2019 /PRNewswire/ -- iCAN: Israel-Cannabis, the world's premier cannabis technology incubator and owner of the CannaTech event platform, announced the formation of Psychedeli-Tech (PsyTech), a new and exciting conference and discovery platform for psychedelic medicine. While cannabis innovation aligns with the regulatory expansion over the past 5 y

NESS ZIONA, Israel, Nov. 18, 2019 /PRNewswire/ -- Kadimastem (TASE: KDST), a clinical stage cell therapy company, today announced its intention to submit an amendment of its ongoing Phase 1/2a clinical trial for the treatment of ALS patients to the Ethics Committee and the Israeli Ministry of Health.AstroRx®, an "off-the-shelf"

THOUSAND OAKS, Calif., SOUTH SAN FRANCISCO, Calif., and SURESNES, France, Nov. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier announced that new results from COSMIC-HF (Chronic Oral Study of Myosin Activation to Incr